Recurrent Stroke Prevention Clinical Outcome Study

NCT01198496 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

5000

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Stroke
Blood Pressure

Interventions

DRUG: Losartan, Losartan and HCTZ, Amlodipine , Spironolactone

Sponsor

Biomedis International Ltd.